C07D213/71

PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING

The invention provides novel inhibitors of hedgehog signaling that are useful as a therapeutic agents for treating malignancies where the compounds have the general formula I:

##STR00001##

wherein A, X, Y R.sub.1, R.sub.2, R.sub.3, R.sub.4, m and n are as described herein.

ETHER COMPOUND AND HARMFUL ARTHROPOD-CONTROLLING COMPOSITION CONTAINING SAME

The present invention provides a compound having an excellent control effect against harmful arthropods, which is represented by formula (I) [wherein A.sup.1 represents CR.sup.1b etc., A.sup.2 represents CR.sup.1c etc., T represents a C1-C10 chain hydrocarbon group which is substituted with one or more halogen atoms etc., Q represents an oxygen atom etc., R.sup.1a, R.sup.1b and R.sup.1c are identical to or different from each other, and each represents a C1-C6 alkyl group etc., R.sup.2 represents a C1-C6 alkyl group etc., R.sup.3 represents a C1-C6 chain hydrocarbon group etc., n is 0, 1 or 2, and q is 0, 1, 2 or 3.],

as well as a composition for controlling harmful arthropod comprising the same compound, and a method for controlling harmful arthropod comprising applying the same compound.

##STR00001##

Compounds and compositions for treating conditions associated with NLRP activity

In one aspect, compounds of Formula AA, or a pharmaceutically acceptable salt thereof, are featured: ##STR00001## or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula A can be as defined anywhere herein.

HYDROCARBYLSULFONYL-SUBSTITUTED PYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER

There is provided compounds of formula I (I) or pharmaceutically-acceptable salts thereof, wherein L, R.sup.1, R.sup.2, R.sup.3 and X have meanings provided in the description, which compounds are useful in the treatment of cancers.

##STR00001##

HYDROCARBYLSULFONYL-SUBSTITUTED PYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER

There is provided compounds of formula I (I) or pharmaceutically-acceptable salts thereof, wherein L, R.sup.1, R.sup.2, R.sup.3 and X have meanings provided in the description, which compounds are useful in the treatment of cancers.

##STR00001##

Compounds and compositions for treating conditions associated with NLRP activity
11760735 · 2023-09-19 · ·

In one aspect, compounds of Formulae (I) and (II), or pharmaceutically acceptable salts thereof, are featured; Formula (I), Formula (II) or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formulae (I) and (II) can be as defined anywhere herein. ##STR00001##

Compounds and compositions for treating conditions associated with NLRP activity
11760735 · 2023-09-19 · ·

In one aspect, compounds of Formulae (I) and (II), or pharmaceutically acceptable salts thereof, are featured; Formula (I), Formula (II) or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formulae (I) and (II) can be as defined anywhere herein. ##STR00001##

PREPARATION OF SULFONAMIDE HERBICIDE PROCESS INTERMEDIATES

Improved methods for preparing chemical precursors to sulfonyl chloride III, which are important intermediates in the preparation of pyroxsulam herbicide, are provided. Also provided are compounds of Formula III, Formula VII, and IV, wherein R.sup.1 is a C.sub.1-C.sub.6 alkyl, X is Cl or OH, Y is halogen, OH, or OR.sup.2, and R.sup.2 is a C.sub.1-C.sub.6 alkyl.

##STR00001##

PREPARATION OF SULFONAMIDE HERBICIDE PROCESS INTERMEDIATES

Improved methods for preparing chemical precursors to sulfonyl chloride III, which are important intermediates in the preparation of pyroxsulam herbicide, are provided. Also provided are compounds of Formula III, Formula VII, and IV, wherein R.sup.1 is a C.sub.1-C.sub.6 alkyl, X is Cl or OH, Y is halogen, OH, or OR.sup.2, and R.sup.2 is a C.sub.1-C.sub.6 alkyl.

##STR00001##

PYRIDINYL SULFONAMIDE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
20210361637 · 2021-11-25 ·

The invention relates to new pyridinyl sulfonamide derivatives of the formula

##STR00001##

wherein R.sup.1, A and n are as defined herein, to their use as medicaments, to methods for their therapeutic use and to pharmaceutical compositions containing them.